• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
[Application effects of bundle nursing of citric acid extracorporeal anticoagulation on continuous renal replacement therapy of severe burn patients].[枸橼酸体外抗凝集束护理在重度烧伤患者连续性肾脏替代治疗中的应用效果]
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2022 Jan 20;38(1):29-37. doi: 10.3760/cma.j.cn501120-20201201-00511.
2
[Effects of citric acid on patients with severe burn complicated with acute renal injury treated by continuous renal replacement therapy].[柠檬酸对连续性肾脏替代治疗的重度烧伤合并急性肾损伤患者的影响]
Zhonghua Shao Shang Za Zhi. 2019 Aug 20;35(8):568-573. doi: 10.3760/cma.j.issn.1009-2587.2019.08.003.
3
[Multicenter retrospect analysis of early clinical features and analysis of risk factors on prognosis of elderly patients with severe burns].老年重度烧伤患者早期临床特征的多中心回顾性分析及预后危险因素分析
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2024 Mar 20;40(3):249-257. doi: 10.3760/cma.j.cn501225-20230808-00042.
4
[Effects of regional citrate anticoagulation in continuous veno-venous hemofiltration of severe burn patients].[局部枸橼酸抗凝在重度烧伤患者连续性静脉-静脉血液滤过中的作用]
Zhonghua Shao Shang Za Zhi. 2021 Dec 20;37(12):1137-1142. doi: 10.3760/cma.j.cn501120-20200816-00381.
5
[Safety and efficacy of regional citrate anticoagulation in continuous renal replacement therapy in the presence of acute kidney injury after hepatectomy].[肝切除术后急性肾损伤患者连续性肾脏替代治疗中局部枸橼酸抗凝的安全性与有效性]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018 Aug;30(8):777-782. doi: 10.3760/cma.j.issn.2095-4352.2018.08.013.
6
Comparison of curative effect between different anticoagulation regimens in continuous renal replacement therapy after cardiac valve replacement.心脏瓣膜置换术后持续肾脏替代治疗中不同抗凝方案的疗效比较
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020 Aug 28;45(8):941-947. doi: 10.11817/j.issn.1672-7347.2020.190750.
7
[Establishment and validation of a risk prediction model for disseminated intravascular coagulation patients with electrical burns].[电烧伤并发弥散性血管内凝血患者风险预测模型的建立与验证]
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2023 Aug 20;39(8):738-745. doi: 10.3760/cma.j.cn501225-20230419-00132.
8
[Effects of application of citrate anticoagulation in bedside continuous blood purification of severe burn patients with sepsis].[枸橼酸盐抗凝在重症烧伤脓毒症患者床边连续性血液净化中的应用效果]
Zhonghua Shao Shang Za Zhi. 2018 Feb 20;34(2):73-77. doi: 10.3760/cma.j.issn.1009-2587.2018.02.003.
9
[Retrospective study of fiberoptic bronchoscopy airway lavage in the treatment of extremely severe burn patients with severe inhalation injury].[纤维支气管镜气道灌洗治疗特重度烧伤合并重度吸入性损伤患者的回顾性研究]
Zhonghua Shao Shang Za Zhi. 2020 Apr 20;36(4):252-259. doi: 10.3760/cma.j.cn501120-20191203-00451.
10
[Influencing factors and their predictive value of skin graft survival after Meek grafting in severe burn patients].[严重烧伤患者Meek植皮术后皮片存活的影响因素及其预测价值]
Zhonghua Shao Shang Za Zhi. 2021 Mar 20;37(3):243-249. doi: 10.3760/cma.j.cn501120-20201127-00503.

本文引用的文献

1
Early application of continuous high-volume haemofiltration can reduce sepsis and improve the prognosis of patients with severe burns.早期应用持续高容量血液滤过可降低脓毒症发生率,改善严重烧伤患者的预后。
Crit Care. 2018 Jul 6;22(1):173. doi: 10.1186/s13054-018-2095-9.
2
Continuous Renal Replacement Therapy: Forty-year Anniversary.连续性肾脏替代治疗:四十周年纪念
Int J Artif Organs. 2017 Jun;40(6):257-264. doi: 10.5301/ijao.5000610.
3
Epidemiology of pediatric burns in southwest China from 2011 to 2015.2011年至2015年中国西南部儿童烧伤的流行病学情况
Burns. 2017 Sep;43(6):1306-1317. doi: 10.1016/j.burns.2017.03.004. Epub 2017 Mar 31.
4
Implementation of a Simplified Regional Citrate Anticoagulation Protocol for Post-Dilution Continuous Hemofiltration Using a Bicarbonate Buffered, Calcium Containing Replacement Solution.使用碳酸氢盐缓冲含钙置换液,为后稀释连续性血液滤过实施简化的局部枸橼酸盐抗凝方案。
Blood Purif. 2016;42(4):349-355. doi: 10.1159/000452755. Epub 2016 Nov 19.
5
Renal replacement therapy in adult and pediatric intensive care : Recommendations by an expert panel from the French Intensive Care Society (SRLF) with the French Society of Anesthesia Intensive Care (SFAR) French Group for Pediatric Intensive Care Emergencies (GFRUP) the French Dialysis Society (SFD).成人及儿童重症监护中的肾脏替代治疗:法国重症监护学会(SRLF)联合法国麻醉重症监护学会(SFAR)、法国儿童重症监护急救小组(GFRUP)以及法国透析学会(SFD)专家小组的建议
Ann Intensive Care. 2015 Dec;5(1):58. doi: 10.1186/s13613-015-0093-5. Epub 2015 Dec 30.
6
Citrate versus heparin anticoagulation for continuous renal replacement therapy: an updated meta-analysis of RCTs.柠檬酸盐与肝素抗凝在连续肾脏替代治疗中的比较:随机对照试验的更新荟萃分析。
Intensive Care Med. 2015 Dec;41(12):2098-110. doi: 10.1007/s00134-015-4099-0.
7
Safety and efficacy of regional citrate anticoagulation in continuous venovenous hemodialysis in the presence of liver failure: the Liver Citrate Anticoagulation Threshold (L-CAT) observational study.肝衰竭患者连续性静脉-静脉血液透析中局部枸橼酸盐抗凝的安全性和有效性:肝枸橼酸盐抗凝阈值(L-CAT)观察性研究
Crit Care. 2015 Sep 29;19:349. doi: 10.1186/s13054-015-1066-7.
8
[Effects of blood purification in the treatment of patients with burn sepsis].血液净化在烧伤脓毒症患者治疗中的作用
Zhonghua Shao Shang Za Zhi. 2014 Jun;30(3):213-8.
9
Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial.急性肾损伤危重症患者连续性静脉-静脉血液滤过中枸橼酸盐抗凝与全身肝素化的比较:一项多中心随机临床试验
Crit Care. 2014 Aug 16;18(4):472. doi: 10.1186/s13054-014-0472-6.
10
Persistent lymphopenia after diagnosis of sepsis predicts mortality.脓毒症诊断后持续淋巴细胞减少预示着死亡率。
Shock. 2014 Nov;42(5):383-91. doi: 10.1097/SHK.0000000000000234.

[枸橼酸体外抗凝集束护理在重度烧伤患者连续性肾脏替代治疗中的应用效果]

[Application effects of bundle nursing of citric acid extracorporeal anticoagulation on continuous renal replacement therapy of severe burn patients].

作者信息

Li N, Chen H L, Li M J, Luo G X, Yuan Z Q

机构信息

State Key Laboratory of Trauma, Burns and Combined Injury, Institute of Burn Research, the First Affiliated Hospital of Army Medical University (the Third Military Medical University), Chongqing 400038, China.

出版信息

Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2022 Jan 20;38(1):29-37. doi: 10.3760/cma.j.cn501120-20201201-00511.

DOI:10.3760/cma.j.cn501120-20201201-00511
PMID:34954935
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11705250/
Abstract

To explore the application effects of bundle nursing of citric acid extracorporeal anticoagulation on continuous renal replacement therapy (CRRT) of severe burn patients. A non-randomized controlled study was conducted. Forty-six patients who met the inclusion criteria and received regular nursing of citric acid extracorporeal anticoagulation during CRRT in the First Affiliated Hospital of Army Medical University (the Third Military Medical University) from January to December 2017 were included in regular nursing group (30 males and 16 females, aged 42.0 (38.7,47.0) years, with 201 times of CRRT performed), and 48 patients who met the inclusion criteria and received bundle nursing of citric acid extracorporeal anticoagulation during CRRT in the same hospital from January to December 2018 were included in bundle nursing group (32 males and 16 females, aged 41.0 (36.0,46.0) years, with 164 times of CRRT performed). The clinical data of all the patients in the two groups were recorded, including the length of intensive care unit (ICU) stay, total cost of treatment in ICU, cost of CRRT, unplanned ending of treatment, ending of treatment due to operation (with the rates of unplanned ending of treatment and ending of treatment due to operation calculated), times of disposable hemodialysis filter and supporting pipeline filter (hereinafter referred to as filter) with use time>24 h, times of CRRT, and lifetime of filter. For the patients in both groups who continuously received CRRT for 3 days or more from the first treatment, the prothrombin time (PT), activated partial thromboplastin time (APTT), international normalized ratio (INR), total calcium, ionic calcium (with the difference of total calcium or ionic calcium between before and after treatment calculated), creatinine, urea, β microglobulin, cystatin C, platelet count, mean arterial pressure, pH value, oxygenation index, bicarbonate radical, and lactic acid levels before the first treatment (hereinafter referred to as before treatment) and 3 days after the first treatment (hereinafter referred to as after 3 days of treatment). The treatment-related complications of all patients in the two groups were recorded during hospitalization. Data were statistically analyzed with independent sample test, Mann-Whitney test, and chi-square test. Compared with those in regular nursing group, the length of ICU stay was significantly shortened (=-4.71, <0.01), the total cost of treatment in ICU was significantly reduced (=-1.39, <0.01), the cost of CRRT had no significant change (>0.05), the rates of unplanned ending of treatment and ending of treatment due to operation were both significantly decreased (with values of 12.20 and 17.83, respectively, <0.01), the times of filter service time>24 h was increased significantly (=-5.93, <0.01), the times of CRRT were significantly reduced (=-4.75, <0.01), and the filter service life was significantly prolonged (=-9.24, <0.01) among patients in bundle nursing group. Thirty-one patients in bundle nursing group and 28 patients in regular nursing group continuously received CRRT for 3 days or more from the first treatment. Before treatment, PT, APTT, and INR of patients in bundle nursing group were 24.10 (16.08, 39.20) s, 38.81 (32.32, 45.50) s, and 1.17 (1.12, 1.19), respectively, similar to 31.75 (22.99, 40.96) s, 41.82 (35.05, 48.06) s, and 1.15 (1.11, 1.19) of patients in regular nursing group (>0.05); the levels of total calcium and ionic calcium of patients in the two groups were similar (>0.05). After 3 days of treatment, PT, APTT, and INR of patients in bundle nursing group and regular nursing group were 29.06 (20.11, 39.46) s, 35.25 (30.06, 40.28) s, 1.13 (1.09, 1.17) and 36.51 (26.64, 42.92) s, 39.89 (34.81, 46.62) s, 1.14 (1.10, 1.18), respectively, similar to those before treatment (>0.05); the level of ionic calcium of patients in regular nursing group was significantly higher than that before treatment (=-2.08, <0.05); the levels of total calcium and ionic calcium of patients in bundle nursing group were both significantly higher than those before treatment (with values of -3.55 and -3.69, respectively, <0.01); compared with those in regular nursing group, APTT of patients was significantly shorter (=-2.29, <0.05), while the total calcium level of patients was significantly higher in bundle nursing group (=-2.26, <0.05). The difference of total calcium between before and after treatment of patients in bundle nursing group was significantly higher than that in regular nursing group (=-3.15, <0.01). The differences of ionic calcium between before and after treatment of patients in the two groups were similar (>0.05). Before treatment, the level of β microglobulin of patients in bundle nursing group was significantly higher than that in regular nursing group (=-2.84, <0.01), the platelet count of patients in bundle nursing group was significantly lower than that in regular nursing group (=-2.44, <0.05), while the levels of creatinine, urea, cystatin C, mean arterial pressure, pH value, oxygenation index, bicarbonate radical, and lactic acid of patients in the two groups were similar (>0.05). After 3 days of treatment, the levels of creatinine, urea, β microglobulin, cystatin C, pH value, bicarbonate radical, and lactic acid of patients were all significantly lower than those before treatment (with values of -2.10, -2.90, -3.11, -2.02, -2.34, -2.63, and -2.84, respectively, <0.05 or <0.01), while the levels of platelet count, oxygenation index, and mean arterial pressure of patients were all significantly higher than those before treatment in bundle nursing group (with values of -6.65 and -2.40, respectively, =-9.97, <0.05 or <0.01); the levels of creatinine, urea, β microglobulin, cystatin C, platelet count, pH value, bicarbonate radical, and lactic acid of patients were all significantly lower than those before treatment (with values of -5.32, -2.31, -2.41, -2.21, -3.68, -2.93, -2.20, and -2.31, respectively, <0.05 or <0.01), while the oxygenation index and mean arterial pressure of patients were both significantly higher than those before treatment in regular nursing group (=-5.59, =-7.74, <0.01). After 3 days of treatment, compared with those in regular nursing group, the levels of creatinine, cystatin C, platelet count, oxygenation index, bicarbonate radical, and mean arterial pressure of patients were all significantly higher (with values of -2.93, -1.99, -6.39, -2.09, and -2.52, respectively, =-3.28, <0.05 or <0.01), while the levels of urea, β microglobulin, pH value, and lactic acid of patients were all significantly lower (with values of -3.87, -2.58, -4.24, and -2.75, respectively, <0.05 or <0.01) in bundle nursing group. During hospitalization, there were no treatment-related bleeding events or hypernatremia related to citric acid treatment of patients in the two groups. The ratio of total calcium to ionic calcium in one patient in bundle nursing group was >2.5, but there was no manifestation of citric acid accumulation poisoning; 1 patient had hypoionic calcemia, and 1 patient had severe metabolic alkalosis. Five patients had hypoionic calcemia and 2 patients had severe metabolic alkalosis in regular nursing group. The implementation of bundle nursing of citric acid extracorporeal anticoagulation during CRRT for severe burn patients shortens the length of ICU stay, reduces the total cost of treatment in ICU and the occurrence of treatment-related complications, relieves the economic burden of patients, and improves the continuity and quality of treatment.

摘要

探讨枸橼酸体外抗凝集束化护理在重度烧伤患者连续性肾脏替代治疗(CRRT)中的应用效果。进行一项非随机对照研究。选取2017年1月至12月在陆军军医大学第一附属医院(第三军医大学)行CRRT期间符合纳入标准并接受枸橼酸体外抗凝常规护理的46例患者作为常规护理组(男30例,女16例,年龄42.0(38.7,47.0)岁,行CRRT 201次),选取2018年1月至12月在同一医院行CRRT期间符合纳入标准并接受枸橼酸体外抗凝集束化护理的48例患者作为集束化护理组(男32例,女16例,年龄41.0(36.0,46.0)岁,行CRRT 164次)。记录两组所有患者的临床资料,包括重症监护病房(ICU)住院时间、ICU治疗总费用、CRRT费用、治疗计划外结束、因手术导致的治疗结束情况(计算治疗计划外结束率和因手术导致的治疗结束率)、使用时间>24 h的一次性血液透析滤器及配套管路滤器(以下简称滤器)次数、CRRT次数及滤器使用寿命。对两组中从首次治疗开始连续接受CRRT 3天及以上的患者,检测首次治疗前(以下简称治疗前)及首次治疗后3天(以下简称治疗3天后)的凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、国际标准化比值(INR)、总钙、离子钙(计算治疗前后总钙或离子钙的差值)、肌酐、尿素、β微球蛋白、胱抑素C、血小板计数、平均动脉压、pH值、氧合指数、碳酸氢根及乳酸水平。记录两组所有患者住院期间与治疗相关的并发症。采用独立样本t检验、Mann-Whitney U检验及卡方检验进行统计学分析。与常规护理组相比,集束化护理组患者的ICU住院时间显著缩短(t=-4.71,P<0.01),ICU治疗总费用显著降低(t=-1.39,P<0.01),CRRT费用无显著变化(P>0.05),治疗计划外结束率和因手术导致的治疗结束率均显著降低(卡方值分别为12.20和17.83,P<0.01),滤器使用时间>24 h的次数显著增加(t=-5.93,P<0.01),CRRT次数显著减少(t=-4.75,P<0.01),滤器使用寿命显著延长(t=-9.24,P<0.01)。集束化护理组31例患者和常规护理组28例患者从首次治疗开始连续接受CRRT 3天及以上。治疗前,集束化护理组患者的PT、APTT及INR分别为24.10(16.08,39.20)s、38.81(32.32,45.50)s及1.17(1.12,1.19),与常规护理组患者的31.75(22.99,40.96)s、41.82(35.05,48.06)s及1.15(1.11,1.19)相似(P>0.05);两组患者的总钙和离子钙水平相似(P>0.05)。治疗3天后,集束化护理组和常规护理组患者的PT、APTT及INR分别为29.06(20.11,39.46)s、35.25(30.06,40.28)s、1.13(1.09,1.17)及36.51(26.64,42.92)s、39.89(34.81,46.62)s、1.14(1.10,1.18),与治疗前相似(P>0.05);常规护理组患者的离子钙水平显著高于治疗前(t=-2.08,P<0.05);集束化护理组患者的总钙和离子钙水平均显著高于治疗前(t值分别为-3.55和-3.69,P<0.01);与常规护理组相比,集束化护理组患者的APTT显著缩短(t=-2.29,P<0.05),而总钙水平显著升高(t=-2.26,P<0.05)。集束化护理组患者治疗前后总钙差值显著高于常规护理组(t=-3.15,P<0.01)。两组患者治疗前后离子钙差值相似(P>0.05)。治疗前,集束化护理组患者的β微球蛋白水平显著高于常规护理组(t=-2.84,P<0.01),集束化护理组患者的血小板计数显著低于常规护理组(t=-2.44,P<0.05),而两组患者的肌酐、尿素、胱抑素C、平均动脉压、pH值、氧合指数、碳酸氢根及乳酸水平相似(P>0.05)。治疗3天后,两组患者的肌酐、尿素、β微球蛋白、胱抑素C、pH值、碳酸氢根及乳酸水平均显著低于治疗前(t值分别为-2.10、-2.90、-3.11、-2.02、-2.34、-2.63及-2.84,P<0.05或P<0.01),而集束化护理组患者的血小板计数、氧合指数及平均动脉压均显著高于治疗前(t值分别为-6.65和-2.40,t=-9.97,P<0.05或P<0.01);常规护理组患者的肌酐、尿素、β微球蛋白、胱抑素C、血小板计数、pH值、碳酸氢根及乳酸水平均显著低于治疗前(t值分别为-5.32、-2.31、-2.41、-2.21、-3.68、-2.93、-2.20及-2.31,P<0.05或P<0.01),而常规护理组患者的氧合指数和平均动脉压均显著高于治疗前(t=-5.59,t=-7.74,P<0.01)。治疗3天后,与常规护理组相比,集束化护理组患者的肌酐、胱抑素C、血小板计数、氧合指数、碳酸氢根及平均动脉压均显著升高(t值分别为-2.93、-1.99、-6.39、-2.09及-2.52,t=-3.28,P<0.05或P<